Amazon Allergy Fexofenadine Hydrochloride Tablets Recalled for Failed Impurity Specifications
Amazon-branded Allergy Fexofenadine Hydrochloride Tablets 180 mg are being recalled because testing found an out-of-specification impurity during stability testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall of a drug product with a quality defect (out-of-specification impurity) detected during stability testing. No illnesses or injuries have been reported, and the hazard is based on testing results rather than actual patient harm. Per the rubric, Class II recalls without reported hospitalization or injury typically score 2 (Moderate).
Plain-English summary
Amazon Allergy Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 24 HR, 30 count bottles are being recalled. The product was manufactured by Perrigo Company PLC in the Czech Republic and distributed by Amazon.com Services LLC nationwide in the USA. Lot #1BR0462 with expiration 10/31/2022 is affected.
The recall was initiated due to failed impurities and degradation specifications. During stability testing, an out-of-specification result was obtained for impurity A, indicating the product did not meet required quality standards.
Consumers in possession of this product should stop use and contact Amazon for instructions on return or disposal. The affected product can be identified by the UPC 3 70030 11466 5 and lot number 1BR0462.
The recalled product
- Product
- amazon, Allergy Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 24 HR, 30 count bottle, Made in the Czech Republic, Distributed by: Amazon.com Services LLC 410 Terry Avenue N. Seattle, WA 98109 UPC 3 70030 11466 5
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — Antihistamine
- Hazard
- impurity-degradation
- failed-specifications
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 1BR0462
- Exp 10/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27